Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
WIT heads into its October 15 results with short sellers entrenched and options traders positioned defensively, even as the borrow market has quietly eased over the past month.
The most notable feature of the lending market is the direction of travel. Availability has loosened considerably since early September, when it dropped to near-zero (7.6% at its tightest on September 3), a point at which almost every share in the lending pool was lent out. It has since recovered to roughly 39%, and cost to borrow has pulled back to 3.3%, down from above 4.5% in early September. That easing has not translated into short sellers closing out. Short interest is up 44% over the past month in share terms, a substantial build that followed the availability squeeze rather than preceded it. The ORTEX short score has held steady just below 68, a level consistent with meaningful bearish conviction and well above the midpoint of the range.
Options positioning tells a similar story. Put/call ratio is running at 1.50, slightly above its 20-day average of 1.42 but well within a normal range on a z-score basis. What is notable is the structural level: WIT's PCR has been above 1.0 for almost every session in the past six weeks, reflecting a persistent preference for downside protection rather than a fresh spike ahead of this particular print. The stock itself has done little to change the mood, off around 1.2% on the week and 1.7% over the past month, trading at $1.70.
The analyst picture is skewed negative, though most of the formal coverage is dated. The most recent move came from JP Morgan in June 2026, when analyst Ankur Rudra lowered his price target from $2.20 to $1.70 while maintaining an Underweight rating, putting his target exactly at the current price. Earlier coverage from Goldman Sachs and Bernstein also carried Sell or Underperform ratings, and the consensus has carried a sell bias for some time. There is no bull catalyst visible in the recent analyst record. On valuation, Wipro trades at roughly 11.5x trailing earnings and 6.5x EV/EBITDA, multiples that look modest in isolation but have barely moved in 30 days, suggesting the market sees limited re-rating potential in either direction. The EV/EBITDA multiple ranks in the 93rd percentile on the ORTEX factor model, meaning the stock looks cheap on that metric relative to the broader universe, yet EPS momentum sits in the bottom quartile both on a 30-day and 90-day basis.
Ownership is concentrated in founder-linked vehicles. The top three holders (Zash Traders, Prazim Traders and Hasham Traders) together hold roughly 60% of shares, all reducing their positions at the June reporting date. Azim Premji's trust and personal holdings represent a further 10%. Western institutions are present but small: BlackRock added modestly in the most recent period while Norges Bank trimmed. The most recent insider activity on the EDGAR record dates to May 2026, when both the CEO and CFO made open-market sales at prices between $1.82 and $2.12, with no 10b5-1 plan attached to either set of transactions.
The print on October 15 is therefore a test of whether Wipro can show any acceleration in revenue momentum to justify a re-rating, or whether the combination of persistent short interest, a defensive options posture and a sell-side consensus anchored at current price levels reflects a more durable assessment of the stock's near-term trajectory.
See the live data behind this article on ORTEX.
Open WIT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.